Raloxiheal 60mg Tablet (Raloxifene)

Price range: $73.31 through $146.94Required

United States dollar ($) - USD
  • United States dollar ($) - USD
  • Euro (€) - EUR
  • Canadian dollar ($) - CAD

Pack SizePriceUnit PriceQuantity 
30 Tablet/s$73.31$2.44 / tablet
60 Tablet/s$112.29$1.87 / tablet
90 Tablet/s$146.94$1.63 / tablet
Want to order in bulk / get a B2B price? Send Inquiry

Add $199.00 to cart and get free shipping!

16 People watching this product now!
Estimated delivery: November 11, 2026 – November 16, 2026
Written by Dr Ambrose Chan, MD, MD Medically reviewed by Dr. Sabrina Castillon, MD, MD
Last updated on September 29, 2026
Additional information
PackagingQty
Delivery Time6 To 15 days
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Raloxiheal 60mg Tablet (Raloxifene)”

Your email address will not be published. Required fields are marked *

Description

About Raloxiheal 60mg Tablet (Raloxifene)

Medicine information

Active ingredient
Raloxifene hydrochloride
Delivery time
United States, United Kingdom, Canada, Australia: typically 10–14 business days after dispatch; other destinations vary according to the approved Cheap Generic Med shipping framework. These are estimates and customs or local carrier delays may extend delivery. Cheap_Generic_Med_Shipping_Coun…
Indication
Treatment and prevention of osteoporosis in postmenopausal women; reduction of the risk of invasive breast cancer in certain postmenopausal women with osteoporosis or at high risk of invasive breast cancer.
Manufacturer
Healing Pharma India Pvt Ltd
Strength
60 mg
Dosage form
Tablet
Route
Oral

Medicine overview

Raloxiheal 60 mg Tablet contains raloxifene hydrochloride, a selective estrogen receptor modulator (SERM). It is used mainly in postmenopausal women to prevent or treat osteoporosis, a condition in which bones become weaker and more likely to fracture. Raloxifene can also reduce the risk of invasive breast cancer in certain postmenopausal women. Its effects vary between tissues: it acts like estrogen in bone while blocking some estrogen effects in breast tissue.

What it is used for

Raloxifene is used to prevent and treat osteoporosis after menopause. Clinical evidence shows a reduction in vertebral fractures, but a reduction in hip fractures has not been demonstrated. It is also used to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk of invasive breast cancer. It does not treat existing breast cancer and is not indicated to prevent breast cancer recurrence or non-invasive breast cancer.

How it works

Raloxifene is a selective estrogen receptor modulator. This means it can produce estrogen-like effects in some tissues while blocking estrogen activity in others. In bone, it reduces the increased bone breakdown associated with menopause, helping maintain bone mineral density. In breast tissue, raloxifene acts mainly as an estrogen antagonist, blocking estrogen-mediated activity. This explains its roles in postmenopausal osteoporosis and in reducing the risk of certain estrogen-sensitive invasive breast cancers.

How it is taken

Raloxifene tablets are taken by mouth. The established raloxifene regimen is 60 mg once daily, and the tablet may be taken at any time of day with or without food. Take it consistently according to the prescription. Adequate calcium and vitamin D intake is important during osteoporosis treatment, and supplementation may be advised when dietary intake is insufficient. Do not alter or stop prescribed treatment without discussing it with the prescriber.

Important warnings

Raloxifene increases the risk of venous thromboembolism, including deep-vein thrombosis and pulmonary embolism, and should not be used by women with an active or previous venous thromboembolism. It should be stopped at least 72 hours before and during prolonged immobilization. Seek urgent medical attention for unexplained leg swelling or pain, sudden chest pain, shortness of breath, coughing blood, or sudden vision changes. An increased risk of death from stroke has been observed in postmenopausal women with coronary heart disease or a high risk of major coronary events. Raloxifene is not intended to prevent cardiovascular disease. Use requires particular caution with liver or kidney impairment and a history of estrogen-associated hypertriglyceridemia. Concurrent systemic estrogen treatment is not recommended. Cholestyramine substantially reduces raloxifene absorption and is not recommended with it; patients taking warfarin or similar coumarin anticoagulants may require monitoring of prothrombin time when raloxifene is started or stopped.

Side effects and monitoring

Common adverse effects include hot flushes, leg cramps, swelling of the hands or feet, sweating, joint pain and flu-like symptoms. Serious but less common risks include blood clots in the legs, lungs or retinal veins and, in certain women at cardiovascular risk, death due to stroke. Obtain urgent medical help for sudden breathlessness, chest pain, coughing blood, one-sided leg swelling or pain, or sudden visual changes. Unexpected vaginal bleeding should be medically assessed. Women using raloxifene for breast-cancer risk reduction should continue recommended breast examinations and mammography; raloxifene does not eliminate breast-cancer risk.

Pregnancy

Raloxifene is contraindicated during pregnancy because it may cause fetal harm. It is intended for postmenopausal women and should not be used by women who are pregnant or may become pregnant.

Breastfeeding

Raloxifene is intended for postmenopausal women and should not be used by nursing women. If breastfeeding is relevant, medical advice should be obtained before exposure to the medicine.

Food, drink and interactions

No specific direct alcohol interaction is established in the prescribing information. For osteoporosis care, avoiding excessive alcohol intake is advised because heavy alcohol consumption can adversely affect bone health.

Food and drink

Raloxifene may be taken with or without food. There is no requirement to coordinate the tablet with meals.

Storage

Store raloxifene tablets at controlled room temperature, generally 20°C to 25°C (68°F to 77°F), and keep them out of the reach of children.

Frequently asked questions

Can raloxifene make hot flushes worse?

Yes. Hot flushes are a recognized common side effect of raloxifene, particularly around the start of treatment. Discuss troublesome or persistent symptoms with your healthcare professional.

Does raloxifene cause blood clots?

It can increase the risk of blood clots in the legs and lungs. It should not be used if you have an active or previous venous blood clot, and sudden leg swelling, chest pain or shortness of breath requires urgent medical attention.

Do I need to stop raloxifene before surgery or a long period of bed rest?

Usually, yes. Prescribing information advises stopping raloxifene at least 72 hours before and during prolonged immobilization because remaining inactive can further increase blood-clot risk. Follow the instructions of the clinician managing your treatment.

Can I take raloxifene with food?

Yes. Raloxifene can be taken with or without food and at any time of day.

Does raloxifene treat breast cancer?

No. Raloxifene can reduce the risk of invasive breast cancer in certain postmenopausal women, but it is not a treatment for existing invasive breast cancer and is not indicated to prevent recurrence.

Do I still need mammograms while taking raloxifene?

Yes. Raloxifene reduces but does not eliminate the risk of invasive breast cancer. Continue breast examinations and mammography according to your healthcare professional's recommended screening schedule.

Can Cheap Generic Med ship Raloxiheal to the United States?

Cheap Generic Med serves the United States under its international shipping model. Delivery is typically estimated at 10–14 business days after dispatch, although customs or carrier delays can extend transit. Prescription and personal-import requirements may apply depending on the customer's circumstances.

Will my Cheap Generic Med order have tracking?

Under the standard fulfilment model, tracked international shipping is used and a tracking number should be provided after dispatch. Carrier systems can take about 24–72 hours to begin showing movement.

Sources

  1. www.healingpharma.in
  2. dailymed.nlm.nih.gov
  3. medlineplus.gov
  4. www.ema.europa.eu
  5. www.cancer.gov

Medical information notice: This information does not replace advice from a qualified healthcare professional. Use prescription medicine only as directed by the prescriber and the approved product information.